Table 6. Differences between patients with positive SSA/SSB and negative SSA/SSB.
| SSA/SSB(+) | SSA/SSB(−) | p | |
| Number of patients, n | 28 | 40 | |
| Years since disease onset, mean ±SD, y | 3.16±1.79 | 2.67±2.79 | 0.62 |
| Times of relapse, mean ±SD, n | 1.96±5.58 | 1.41±1.74 | 0.23 |
| Sex (female/male) | (26/2) | (30/10) | |
| Eyes with ON history, n | 52 | 56 | |
| Age (year) | 44.5±14.96 | 36.56±16.87 | 0.18 |
| RNFL (µm) Average thickness | 70.80±15.72 | 69.78±17.30 | 0.8 |
| Superior quadrant | 82.48±23.54 | 78.44±22.06 | 0.46 |
| Inferior quadrant | 84.95±27.35 | 84.87±31.74 | 0.99 |
| Nasal quadrant | 61.93±11.81 | 61.50±12.41 | 0.88 |
| Temporal quadrant | 50.15±12.85 | 54.06±14.19 | 0.23 |
| Relapse to NMO | 6 (21.43%) | 8 (20%) | 0.88 |
* = p<0.05; ** = p<0.01.